 |
 |

Immunosuppression and CancerImportance in Head and Neck Surgery
Israel Penn, MD
Arch Otolaryngol. 1975;101(11):667-670.
Abstract
 |  |
The immune system is an important factor in the host's defenses against cancer. Immunosuppressive therapy associated with organ transplantation is accompanied by a substantially increased incidence of malignant neoplasms, many of which involve the head and neck. Treatment of carcinoma of the larynx by excision and laryngeal transplantation is not justified because of the complications, including malignant neoplasm, that are associated with immunosuppressive therapy. Cancer chemotherapeutic agents have Immunosuppressive side-effects, and patients have manifested new malignant neoplasms while their original tumors were controlled by the antineoplastic drugs. These findings have important implications for the management of patients with malignant neoplasms, since other forms of cancer treatment, such as radical surgical procedures and radiotherapy, may also impair the host's resistance to cancer. Therefore, we should reappraise our methods of cancer therapy and examine their effects on the host's resistance to his neoplasm.
(Arch Otolaryngol 101:667-670, 1975)
Author Affiliations
From the Department of Surgery, University of Colorado School of Medicine and the Veterans Administration Hospital, Denver.
Footnotes
Accepted for publication July 3, 1975.
Read before the 17th annual meeting of the American Society for Head and Neck Surgery, Atlanta, April 9, 1975.
Reprint requests to the Department of Surgery, Veterans Administration Hospital, 1055 Clermont St, Denver, CO 80220 (Dr Penn).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|